Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Deal includes 13 branded generic products across 55+ countries; acquisition expected to strengthen global anti-infective portfolio and expand regulated market presence
Growth was broad-based across segments
Angelique Kruif brings over 20 years of HR leadership built across a range of international organisations
The move reinforces Croda’s push to fuel growth through high-impact innovation across its Consumer Care portfolio
Move comes amid rising regulatory pressures
Inspection outcome reinforces company's compliance track record and strengthens its ability to serve regulated markets including the United States
The newly formed team is led by Tomabu Adjobimey, an immunologist known for his work in host-pathogen interactions and immune modulation
By prioritising absolute compliance, leveraging the power of digital tools, and aligning with government policies, the sector is locking in its future leadership
In his new role, Curtis will lead the formulation and execution of the company’s global technical strategy
Subscribe To Our Newsletter & Stay Updated
